Pharma Offers View On How To Slow Antimicrobial Resistance, Boost Research 30/04/2015 by Catherine Saez, Intellectual Property Watch 1 Comment the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) provided its recommendations on how to slow down antimicrobial resistance and boost antibiotic research and development. In addition, the association organised a forum on the subject today.
Chile: Study On Pharma Patents Shows Foreign Ownership 30/04/2015 by Elena Bourtchouladze for Intellectual Property Watch Leave a Comment In Chile, pharmaceutical patents are almost exclusively the domain of foreign companies. Only a subset of drugs is protected by patents, while a much larger number of products is protected by trademarks, a study finds, offering for the first time empirical evidence on the use of primary and secondary patents in Chile.
WHO: Too Few Countries Fighting Antimicrobial Resistance; Global Action Plan Advocates Equitable Access 29/04/2015 by Catherine Saez, Intellectual Property Watch 3 Comments The World Health Organization released a report today on countries’ response to the global declining effect of antibiotics on bacteria and microbes, heightened by overuse or misuse of those products. Next month the World Health Assembly will consider a draft global action plan to fight the problem, which includes suggestions for sustainable investment in the area such as de-linking research from price and sales, as well as equitable access to new products.
UAEM Grades US Universities On Research For Neglected Diseases. Spoiler Alert – There’s Room For Improvement 24/04/2015 by William New, Intellectual Property Watch 1 Comment Universities play an enormous role in biomedical research in the United States, but are not doing all they can to advance research for neglected diseases or make their innovations available to people who need them most, the student groupUniversities Allied for Essential Medicines (UAEM) said this week. UAEM released the results of its second annual […]
Divide And Conquer: The New US Strategy To Disentangle The TPP Negotiations 23/04/2015 by Intellectual Property Watch 3 Comments Burcu Kilic & Pablo Viollier write: Political leaders in Washington and other Trans-Pacific Partnership (TPP) negotiating countries have set the end of May as the latest deadline for completion of the talks. The negotiations have already missed several such deadlines, so who really knows? No one. But there is something we all know: TPP raises significant concerns because negotiations are being held behind closed doors with details kept secret even from the legislatures in TPP countries.
Open, Online Database Of Clinical Trials Planned 22/04/2015 by Intellectual Property Watch Leave a Comment A newly announced project will create an open, online database of information about the clinical research trials worldwide. The initiative, called Open Trials, will be directed by Ben Goldacre, an internationally known author (“Bad Science”) and advocated for clinical transparency. As announced by Open Knowledge yesterday, Open Trials “will aggregate information from a wide variety […]
WHO Reviews Its Essential Medicines List; Some New Candidates Under Patent 21/04/2015 by Catherine Saez, Intellectual Property Watch 1 Comment The World Health Organization is reviewing its list of essential medicines this week. Over 70 candidate medicines are expected to be assessed by an Expert Committee. Some of those medicines are under patent and highly priced, which poses an accessibility challenge.
WHO Opens Its Database Of Medicines Side Effects To The Public 20/04/2015 by Catherine Saez, Intellectual Property Watch 1 Comment The World Health Organization has announced that its Global Medicines Safety Database is now open to the general public. The database named VigiAccess can now be accessed on any computer or smartphone in the world.
Experts Debate Medicines Access In South Africa And Beyond 15/04/2015 by Linda Daniels for Intellectual Property Watch 2 Comments CAPE TOWN – Pharmaceutical patents and access to medicines was the focus of an animated panel discussion by experts offering divergent views on the topic at intellectual property group FICPI’s 2015 World Congress, currently underway in Cape Town, South Africa.
Clinical Trial Transparency, Medicines Access On Agendas Today 14/04/2015 by William New, Intellectual Property Watch Leave a Comment The World Health Organization today issued a call for disclosure of results from clinical trials for medical products, no matter what the results of the trials were. And a variety of events and publications are addressing medicines access today.